Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuronox vs BOTOX for moderate to severe glabellar lines
CTR20160158Phase 3Completed
- Sponsor
- Medytox Inc.
- Start
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in glabellar furrowing, sponsored by Medytox Inc.. Started Mar 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on CTR20160158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160158.